{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"2032f2e576d9677b815eb6a12fc700c517982f7a4c4be09b23ab5b34e85afeb7","attributes":{"feedName":"medwatch","feedSource":"medwatch","title":"Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL in the Carpujectâ„¢ Single-use Cartridge Syringe System by Hospira: Recall - Due to the Potential Presence of Particulate Matter","description":"The patient has a low likelihood of experiencing adverse events ranging from local irritation, allergic reactions, phlebitis, end-organ granuloma, tissue ischemia, pulmonary emboli, pulmonary dysfunction, pulmonary infarction, and toxicity.","link":"https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm609803.htm","publicationDate":"2018-06-04T04:00:00.000Z","state":"sent","affected":[],"allergens":[],"audience":["professionals"],"categories":["drugs"],"contaminants":[],"distribution":["AL","AK","AZ","AR","CA","CO","CT","DE","DC","FL","GA","HI","ID","IL","IN","IA","KS","KY","LA","ME","MD","MA","MI","MN","MS","MO","MT","NE","NV","NH","NJ","NM","NY","NC","ND","OH","OK","OR","PA","RI","SC","SD","TN","TX","UT","VT","VA","WA","WV","WI","WY"],"risk":"possible","token":"5d9e68818b079e002a25098b"}}}